Type
. [Incidence of leprosy in Yemen, and neurologic and skin symptoms in this disease]. Vestnik dermatologii i venerologii. 1969;43(3):74-6.
Type
. Results after five years of intensive leprosy control work in a highly endemic area. Leprosy review [Internet]. 1969;40(4):211-6. Available from: http://leprev.ilsl.br/pdfs/1969/v40n4/pdf/v40n4a05.pdf
Type
. Leprosy control work at Polambakkam and its critical appraisal. Leprosy review [Internet]. 1969;40(4):203-9. Available from: http://leprev.ilsl.br/pdfs/1969/v40n4/pdf/v40n4a04.pdf
Type
. Control of leprosy. Leprosy review [Internet]. 1969;40(4):191-4. Available from: http://leprev.ilsl.br/pdfs/1969/v40n4/pdf/v40n4a01.pdf
Type
. B 663 (Lampren) in mycobacterial infections. The British journal of dermatology. 1969;81(10):794-5.
Type
. [Thalidomide in the treatment of leprosy reactions. 3 years of experience in Mexico]. Gaceta medica de Mexico. 1969;99(10):917-31.
Type
. Tuberculoid leprosy in state of reaction. Archives of dermatology. 1969;100(4):515-6.
Type
. Altered immunity and cancer risk: a review of the problem and analysis of the cancer mortality experience of leprosy patients. Journal of the National Cancer Institute. 1969;43(4):775-81.
Type
. [Hansen's disease, a difficult diagnosis?]. Nederlands tijdschrift voor geneeskunde. 1969;113(39):1686-7.
Type
. [Dispensary care for patients with leprosy and the tasks of dermato-venerologic institutions]. Vestnik dermatologii i venerologii. 1969;43(9):67-72.